FDA Moves to Reevaluate Several Peptides American Med Spa Association BPC 157 and the Difference Between an Evidence Gap and a Cover Up: What the entire human evidence base actually looks like, and the questions to ask next. WellFounded Founders Health & FDA to weigh easing limits on unproven peptides FDA Moves on Peptides: What Compounding Pharmacies Need to Know The Peptide Craze Part 2: BPC 157, NAD and the Truth Behind the Longevity Molecule Hype